---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-079575"
form_type: "8-K"
ticker: "ARWR"
cik: "0000879407"
company_name: "ARROWHEAD PHARMACEUTICALS, INC."
filed_at: "2022-03-18T23:59:59+00:00"
generated_at: "2026-06-26T21:51:23.345406+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Arrowhead shareholders reject advisory pay plan and director comp plan at annual meeting

## Summary
- Advisory vote on executive compensation: 54.8M against vs 14.2M for; proposal fails.
- Non-Employee Director Compensation Plan: 52.5M against vs 16.0M for; proposal fails.
- Three directors (Ferrari, Perry, Waddill) received majority AGAINST votes (44.4M, 39.8M, 42.7M resp.).
- Ratification of auditors (Rose Snyder & Jacobs) passed with 87.2M votes for.
- Approx. 20.2M broker non-votes on all proposals except auditor ratification.

## SEC filing metadata
- accession: 0001193125-22-079575
- form_type: 8-K
- ticker: ARWR
- cik: 0000879407
- company_name: ARROWHEAD PHARMACEUTICALS, INC.
- filed_at: 2022-03-18T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/879407/000119312522079575/0001193125-22-079575-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/879407/000119312522079575/d321053d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-079575
- JSON: https://secwatch.observer/filing/0001193125-22-079575.json
- Plain text: https://secwatch.observer/filing/0001193125-22-079575.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.